Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer

Japanese Journal of Clinical Oncology

Volumn 41, Issue 8, 2011, Pages 1007-1012

  Kawaguchi, Yoshifumi ^a   Nishiyama, Kinji ^a   Miyagi, Ken ^a   Suzuki, Osamu ^a   Ito, Yuri ^a   Nakamura, Satoaki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Lymph node failure; Radiation field

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; OVERALL SURVIVAL; PRIMARY TUMOR; RADIATION FIELD; SURVIVAL RATE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 79961056748     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr069     Document Type: Article

References (21)

1. The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan-2009. Tokyo: Foundation for Promotion of Cancer Research.
2. Sobin LH, Gospodarowicz MK, Wittekind C (editors). TNM Classification of Malignant Tumours. 7th edn. New York: John Wiley and Sons, Inc. 2009.
3. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998;123:432-9.
4. Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys 2006;64:1106-11.
5. Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009;39:638-43.
6. Slevin NJ, Stout R. Carcinoma of the oesophagus-a review of 108 cases treated by radical radiotherapy. Clin Radiol 1989;40:200-3.
7. Kato H, Tachimori Y, Mizobuchi S, Igaki H, Ochiai A. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus. Cancer 1993;72:2879-82.
8. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 1995;76:178-86.
9. Okawa T, Tanaka M, Kita-Okawa M, Nishio M, Kikuchi Y, Shirato H, et al. Superficial esophageal cancer: multicenter analysis of results of definitive radiation therapy in Japan. Radiology 1995;196:271-4.
10. Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990;19:237-44.
11. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-9.
12. Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163-70.
13. Nishimura Y, Ono K, Tsutsui K, Oya N, Okajima K, Hiraoka M, et al. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 1994;30:1099-105.
14. Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009;70:860-6.
15. Ishikawa H, Sakurai H, Tamaki Y, Nonaka T, Yamakawa M, Saito Y, et al. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy. J Gastroenterol Hepatol 2006;21:1290-6.
16. The Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan. 3rd edn. Chiba, Japan: The Japan Esophageal Society 2002.
17. Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, et al. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol 2009;92:266-9.
18. Inoue H, Endo M, Takeshita K, Kawano T, Goseki N, Takiguchi T, et al. Endoscopic resection of early-stage esophageal cancer. Surg Endosc 1991;5:59-62.
19. Fujimaki M, Nakayama K. Endoscopic laser treatment of superficial esophageal cancer. Semin Surg Oncol 1986;2:248-56.
20. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-702.
21. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-74.